Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis

Diabetes Care - Tập 39 Số 5 - Trang 833-846 - 2016
Marta Guasch‐Ferré1,2,3, Adela Hruby2, Estefanía Toledo4, Clary B. Clish5, Miguel Ángel Martínez‐González4, Jordi Salas‐Salvadó1,3, Frank B. Hu6,7,2
1CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain
2Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
3Human Nutrition Unit, Faculty of Medicine and Health Sciences, Pere Virgili Institute for Health Research, Rovira i Virgili University, Reus, Spain
4Department of Preventive Medicine and Public Health, University of Navarra, Health Research Institute of Navarra, Pamplona, Spain
5Broad Institute, Cambridge, MA
6Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
7Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA

Tóm tắt

OBJECTIVE To conduct a systematic review of cross-sectional and prospective human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on prediabetes and type 2 diabetes. RESEARCH DESIGN AND METHODS We searched MEDLINE and EMBASE databases through August 2015. We conducted a qualitative review of cross-sectional and prospective studies. Additionally, meta-analyses of metabolite markers, with data estimates from at least three prospective studies, and type 2 diabetes risk were conducted, and multivariable-adjusted relative risks of type 2 diabetes were calculated per study-specific SD difference in a given metabolite. RESULTS We identified 27 cross-sectional and 19 prospective publications reporting associations of metabolites and prediabetes and/or type 2 diabetes. Carbohydrate (glucose and fructose), lipid (phospholipids, sphingomyelins, and triglycerides), and amino acid (branched-chain amino acids, aromatic amino acids, glycine, and glutamine) metabolites were higher in individuals with type 2 diabetes compared with control subjects. Prospective studies provided evidence that blood concentrations of several metabolites, including hexoses, branched-chain amino acids, aromatic amino acids, phospholipids, and triglycerides, were associated with the incidence of prediabetes and type 2 diabetes. We meta-analyzed results from eight prospective studies that reported risk estimates for metabolites and type 2 diabetes, including 8,000 individuals of whom 1,940 had type 2 diabetes. We found 36% higher risk of type 2 diabetes per study-specific SD difference for isoleucine (pooled relative risk 1.36 [1.24–1.48]; I2 = 9.5%), 36% for leucine (1.36 [1.17–1.58]; I2 = 37.4%), 35% for valine (1.35 [1.19–1.53]; I2 = 45.8%), 36% for tyrosine (1.36 [1.19–1.55]; I2 = 51.6%), and 26% for phenylalanine (1.26 [1.10–1.44]; I2 = 56%). Glycine and glutamine were inversely associated with type 2 diabetes risk (0.89 [0.81–0.96] and 0.85 [0.82–0.89], respectively; both I2 = 0.0%). CONCLUSIONS In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.

Từ khóa


Tài liệu tham khảo

International Diabetes Federation, 2013, IDF Diabetes Atlas

Hu, 2015, Curbing the diabetes pandemic: the need for global policy solutions, JAMA, 313, 2319, 10.1001/jama.2015.5287

Roberts, 2014, Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome, Lancet Diabetes Endocrinol, 2, 65, 10.1016/S2213-8587(13)70143-8

Nicholson, 2008, Systems biology: Metabonomics, Nature, 455, 1054, 10.1038/4551054a

Wang, 2011, Metabolite profiles and the risk of developing diabetes, Nat Med, 17, 448, 10.1038/nm.2307

Floegel, 2013, Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach, Diabetes, 62, 639, 10.2337/db12-0495

Padberg, 2014, A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology, PLoS One, 9, e85082, 10.1371/journal.pone.0085082

Würtz, 2012, Circulating metabolite predictors of glycemia in middle-aged men and women, Diabetes Care, 35, 1749, 10.2337/dc11-1838

Rhee, 2011, Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans, J Clin Invest, 121, 1402, 10.1172/JCI44442

American Diabetes Association, 2011, Diagnosis and classification of diabetes mellitus, Diabetes Care, 34, S62, 10.2337/dc11-S062

Hayden, 2006, Evaluation of the quality of prognosis studies in systematic reviews, Ann Intern Med, 144, 427, 10.7326/0003-4819-144-6-200603210-00010

Stancáková, 2012, Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men, Diabetes, 61, 1895, 10.2337/db11-1378

Ferrannini, 2013, Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance, Diabetes, 62, 1730, 10.2337/db12-0707

Hasselblad, 1995, Meta-analysis of screening and diagnostic tests, Psychol Bull, 117, 167, 10.1037/0033-2909.117.1.167

da Costa, 2012, Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study, Int J Epidemiol, 41, 1445, 10.1093/ije/dys124

Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629

Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446

Tai, 2010, Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men, Diabetologia, 53, 757, 10.1007/s00125-009-1637-8

Newgard, 2009, A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance, Cell Metab, 9, 311, 10.1016/j.cmet.2009.02.002

Lucio, 2010, Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach, PLoS One, 5, e13317, 10.1371/journal.pone.0013317

Gall, 2010, Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population, PLoS One, 5, e10883, 10.1371/journal.pone.0010883

Würtz, 2012, Metabolic signatures of insulin resistance in 7,098 young adults, Diabetes, 61, 1372, 10.2337/db11-1355

Ho, 2013, Metabolite profiles during oral glucose challenge, Diabetes, 62, 2689, 10.2337/db12-0754

Geidenstam, 2014, Metabolite profile deviations in an oral glucose tolerance test-a comparison between lean and obese individuals, Obesity (Silver Spring), 22, 2388, 10.1002/oby.20868

Haus, 2009, Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance, Diabetes, 58, 337, 10.2337/db08-1228

Zhang, 2009, Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses, J Proteome Res, 8, 5188, 10.1021/pr900524z

Mihalik, 2010, Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity, Obesity (Silver Spring), 18, 1695, 10.1038/oby.2009.510

Fiehn, 2010, Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women, PLoS One, 5, e15234, 10.1371/journal.pone.0015234

Zhou, 2013, Obesity and diabetes related plasma amino acid alterations, Clin Biochem, 46, 1447, 10.1016/j.clinbiochem.2013.05.045

Menni, 2013, Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach, Diabetes, 62, 4270, 10.2337/db13-0570

Xu, 2013, Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics, J Clin Endocrinol Metab, 98, E1060, 10.1210/jc.2012-4132

Meikle, 2013, Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes, PLoS One, 8, e74341, 10.1371/journal.pone.0074341

Thalacker-Mercer, 2014, BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans, Diabetes, 63, 791, 10.2337/db13-0396

Messana, 1998, Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients, Clin Chem, 44, 1529, 10.1093/clinchem/44.7.1529

Wang, 2005, Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis, Anal Chem, 77, 4108, 10.1021/ac0481001

Yuan, 2007, A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile, J Chromatogr B Analyt Technol Biomed Life Sci, 850, 236, 10.1016/j.jchromb.2006.11.035

Li, 2009, Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus, Anal Chim Acta, 633, 257, 10.1016/j.aca.2008.11.058

Adams, 2009, Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women, J Nutr, 139, 1073, 10.3945/jn.108.103754

Zhang, 2009, Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system, Anal Chim Acta, 650, 16, 10.1016/j.aca.2009.02.027

Suhre, 2010, Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting, PLoS One, 5, e13953, 10.1371/journal.pone.0013953

Ha, 2012, The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes, Clin Endocrinol (Oxf), 76, 674, 10.1111/j.1365-2265.2011.04244.x

Kaur, 2013, Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes, Mol Biosyst, 9, 307, 10.1039/C2MB25384D

Zhang, 2014, Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods, J Physiol Biochem, 70, 117, 10.1007/s13105-013-0286-z

Wang-Sattler, 2012, Novel biomarkers for pre-diabetes identified by metabolomics, Mol Syst Biol, 8, 615, 10.1038/msb.2012.43

Cheng, 2012, Metabolite profiling identifies pathways associated with metabolic risk in humans, Circulation, 125, 2222, 10.1161/CIRCULATIONAHA.111.067827

Mahendran, 2013, Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men, Diabetes Care, 36, 3732, 10.2337/dc13-0800

Mahendran, 2013, Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men, Diabetes, 62, 3618, 10.2337/db12-1363

Wang, 2013, 2-Aminoadipic acid is a biomarker for diabetes risk, J Clin Invest, 123, 4309, 10.1172/JCI64801

Palmer, 2015, Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study, J Clin Endocrinol Metab, 100, E463, 10.1210/jc.2014-2357

Drogan, 2015, Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study, Clin Chem, 61, 487, 10.1373/clinchem.2014.228965

Zhao, 2015, Novel metabolic markers for the risk of diabetes development in American Indians, Diabetes Care, 38, 220, 10.2337/dc14-2033

Fizelova, 2015, Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men, Atherosclerosis, 240, 272, 10.1016/j.atherosclerosis.2015.03.034

Tillin, 2015, Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study, Diabetologia, 58, 968, 10.1007/s00125-015-3517-8

Shah, 2012, Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss, Diabetologia, 55, 321, 10.1007/s00125-011-2356-5

Würtz, 2013, Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults, Diabetes Care, 36, 648, 10.2337/dc12-0895

Cobb, 2013, A novel fasting blood test for insulin resistance and prediabetes, J Diabetes Sci Technol, 7, 100, 10.1177/193229681300700112

Krebs, 2002, Mechanism of amino acid-induced skeletal muscle insulin resistance in humans, Diabetes, 51, 599, 10.2337/diabetes.51.3.599

Yano, 2011, Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice, J Biol Chem, 286, 3992, 10.1074/jbc.M110.179176

Horie, 1981, Changes in peroxisomal fatty acid oxidation in the diabetic rat liver, J Biochem, 90, 1691, 10.1093/oxfordjournals.jbchem.a133645

Kahn, 1998, Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance, Cell, 92, 593, 10.1016/S0092-8674(00)81125-3

McGill, 2004, Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay, Diabetes Care, 27, 1859, 10.2337/diacare.27.8.1859

Ley, 2014, Prevention and management of type 2 diabetes: dietary components and nutritional strategies, Lancet, 383, 1999, 10.1016/S0140-6736(14)60613-9

Cornelis, 2013, Systems epidemiology: a new direction in nutrition and metabolic disease research, Curr Nutr Rep, 2, 10.1007/s13668-013-0052-4

Tzoulaki, 2014, Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies, Am J Epidemiol, 180, 129, 10.1093/aje/kwu143

Thông tin
Thông tin xuất bản

Diabetes Care

Tập 39 Số 5

833-846

Thông tin tác giả